- Home
- MCW vs NRIX Comparison
MCW vs NRIX Comparison
Compare MCW & NRIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MCW | NRIX |
|---|---|---|
| Founded | 1996 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.6B |
| IPO Year | 2021 | 2020 |
Fundamental Metrics
Financial Performance| Metric | MCW | NRIX |
|---|---|---|
| Price | $7.02 | $17.50 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 11 | 12 |
| Target Price | $7.28 | ★ $30.50 |
| AVG Volume (30 Days) | ★ 2.2M | 1.2M |
| Earning Date | 04-29-2026 | 04-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 47.62 | N/A |
| EPS | ★ 0.31 | N/A |
| Revenue | ★ $1,051,731,000.00 | $76,987,000.00 |
| Revenue This Year | $7.92 | N/A |
| Revenue Next Year | $7.05 | $40.12 |
| P/E Ratio | $22.56 | ★ N/A |
| Revenue Growth | 5.73 | ★ 99.31 |
| 52 Week Low | $4.61 | $8.20 |
| 52 Week High | $7.81 | $22.50 |
Technical Indicators
Market Signals| Indicator | MCW | NRIX |
|---|---|---|
| Relative Strength Index (RSI) | 65.62 | 64.82 |
| Support Level | $6.95 | $16.81 |
| Resistance Level | $7.13 | $19.98 |
| Average True Range (ATR) | 0.02 | 0.92 |
| MACD | -0.01 | 0.23 |
| Stochastic Oscillator | 91.67 | 96.64 |
Price Performance
Historical ComparisonAbout MCW Mister Car Wash Inc.
Mister Car Wash Inc is a car wash brand offering express exterior and interior cleaning services. Express Exterior Locations offers express exterior cleaning services and Interior Cleaning Locations offers both express exterior and interior cleaning services. The company recognizes revenue from activities related to providing car wash services at its car wash locations that are geographically diversified throughout the United States and have similar economic characteristics and nature of services.
About NRIX Nurix Therapeutics Inc.
Nurix Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and potential commercialization of targeted protein degradation therapies for cancer and inflammatory diseases. It utilizes an integrated discovery platform that incorporates artificial intelligence and ligase expertise to support its research activities. The company's pipeline includes Bexobrutideg (NX-5948), Zelebrudomide (NX-2127), NX-1607 and BRAF degrader. These drug candidates target specific proteins involved in immune and cancer-related pathways. It operates in a single business segment.